Evidence map›Paper›PMID 29078395›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

STAT5-mediated chromatin interactions in superenhancers activate IL-2 highly inducible genes: Functional dissection of the

Peng Li, Suman Mitra, Rosanne Spolski, Jangsuk Oh, Wei Liao, Zhonghui Tang, Fei Mo, Xingwang Li, Erin E West, Daniel Gromer and 4 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Restoration of HBV-specific CD8Signal transduction and targeted therapy · 2021
    Trial
  3. Regulation of immune signal integration and memory by inflammation-induced chromosome conformation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. FOXP-stabilization of thebioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The role of IL-2 in type 2 immunity.Frontiers in immunology · 2025
    Review
  15. A new pipeline SPICE identifies novel JUN-IKZF1 composite elements.bioRxiv : the preprint server for biology · 2024
    Article
  16. Review
  17. Article
  18. Article
  19. Active maintenance of CD8Cell reports · 2023
    Article
  20. Strategies to therapeutically modulate cytokine action.Nature reviews. Drug discovery · 2023
    Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Peng LiLaboratory of Molecular Immunology and Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD 20892; lip3@nhbli.nih.gov wjl@helix.nih.gov.
Suman MitraLaboratory of Molecular Immunology and Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD 20892.
Rosanne SpolskiLaboratory of Molecular Immunology and Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD 20892.
Jangsuk OhLaboratory of Molecular Immunology and Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD 20892.
Wei LiaoLaboratory of Molecular Immunology and Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD 20892.
Zhonghui TangThe Jackson Laboratory for Genomic Medicine, University of Connecticut, Farmington, CT 06030.
Fei MoLaboratory of Molecular Immunology and Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD 20892.
Xingwang LiThe Jackson Laboratory for Genomic Medicine, University of Connecticut, Farmington, CT 06030.
Erin E WestLaboratory of Molecular Immunology and Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD 20892.
Daniel GromerLaboratory of Molecular Immunology and Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD 20892.
Jian-Xin LinLaboratory of Molecular Immunology and Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD 20892.
Chengyu LiuTransgenic Core, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892.
Yijun RuanThe Jackson Laboratory for Genomic Medicine, University of Connecticut, Farmington, CT 06030.
Warren J LeonardLaboratory of Molecular Immunology and Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD 20892; lip3@nhbli.nih.gov wjl@helix.nih.gov.ORCID 0000-0002-5740-7448
National Institutes of Health · USUniversity of Connecticut · USNational Heart Lung and Blood Institute · US

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI William Carl Skarnes · 1985 to 2026
$61.9M
IL-2 Family Cytokines and their Receptors-- Molecular Regulation via STATsZIAHL005402 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI LEONARD, WARREN J · 2009 to 2025
$26.8M
Transgenic CoreZICHL005907 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI LIU, CHENGYU · 2010 to 2025
$25.8M
IL-2 Family Cytokines and their Receptors-- Biology of the IL-21 systemZIAHL005408 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI LEONARD, WARREN J · 2009 to 2025
$23.7M
IL-2 Family Cytokines and their Receptors-- Biology of the IL-2 systemZIAHL005401 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI LEONARD, WARREN J · 2009 to 2025
$22.5M
Nucleome Positioning System for Spatiotemporal Genome Organization and RegulationU54DK107967 · NIDDK · JACKSON LABORATORY · PI WEI, CHIA-LIN · 2015 to 2019
$3.6M
Characterization of RNA-Chromatin Interactome by RNA-DNA Ligation and SequencingR01CA186714 · NCI · JACKSON LABORATORY · PI RUAN, YIJUN · 2014 to 2016
$2.2M
Workshop on Chromatin Interaction Analysis using Paired-End Tag SequencingR25HG007631 · NHGRI · JACKSON LABORATORY · PI RUAN, YIJUN · 2015 to 2017
$157k
NCI NIH HHS P30 CA034196NCI NIH HHS R01 CA186714NHGRI NIH HHS R25 HG007631NIDDK NIH HHS U54 DK107967
6 · The paper itself

Abstract

Cytokines critically control immune responses, but how regulatory programs are altered to allow T cells to differentially respond to distinct cytokine stimuli remains poorly understood. Here, we have globally analyzed enhancer elements bound by IL-2-activated STAT5 and IL-21-activated STAT3 in T cells and identified

Indexed as

Enhancer Elements, GeneticAnimalsBinding SitesCD8-Positive T-LymphocytesChromatinCRISPR-Cas SystemsGene EditingGene Expression RegulationGenes, ReporterGenetic LociHumansInterleukin-2Interleukin-21InterleukinsLuciferasesMiceChromatinInterleukin-2Interleukin-21InterleukinsLuciferasesReceptors, Interleukin-2STAT5 Transcription FactorChIA-PETIL-2Il2ra geneSTAT5superenhancer

Identifiers

PMID29078395
PMCPMC5699083
OpenAlexW2766265235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.